CVE-2026-48019CRLF injection in Laravel's default email rule enables SMTP smuggling and spoofed-mail relay
Updated under an hour ago ()
Does this affect you?
It affects laravel framework. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Laravel is a web application framework. Prior to versions 12.60.0 and 13.10.0, a CRLF injection vulnerability in Laravel's email validation, in combination with how Symfony Mailer and Symfony Mime handle certain character sequences, may allow an unauthenticated attacker to interfere with outbound email processing in applications that send mail to user-supplied addresses. This issue has been patched in versions 12.60.0 and 13.10.0.
- CVSS
- 8.9 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:H/I:H/A:L
- Weakness (CWE)
- CWE-93
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- GitHub_M
- NVD analysis
- Awaiting Analysis
- Record last updated
- Sep 8, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
laravel framework laravel:framework (from the name) | from 13.0.0, < 13.10.0; before 12.60.0 | CNA record |
References
- https://github.com/laravel/framework/security/advisories/GHSA-5vg9-5847-vvmqx-refsource-confirm
- https://github.com/laravel/framework/pull/60151x-refsource-misc
- https://github.com/laravel/framework/commit/96e9a663db657cf37ef26cd794fda8ff60eaa451x-refsource-misc
- https://github.com/laravel/framework/commit/f336ba79e744257f84ebf0d096b0ebc62e8e1a4dx-refsource-misc
- https://github.com/laravel/framework/releases/tag/v12.60.0x-refsource-misc
- https://github.com/laravel/framework/releases/tag/v13.10.0x-refsource-misc
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.